China Health Technology Group Holding Company Limited
CHBOD
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 8.30M | 7.45M | 6.59M | 7.17M | 7.79M |
| Total Other Revenue | -- | -- | -- | 57.70K | 116.70K |
| Total Revenue | 8.30M | 7.45M | 6.59M | 7.17M | 7.79M |
| Cost of Revenue | 8.17M | 7.26M | 6.33M | 6.32M | 6.34M |
| Gross Profit | 128.90K | 196.10K | 261.50K | 849.60K | 1.45M |
| SG&A Expenses | 3.25M | 3.21M | 3.17M | 3.21M | 3.27M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 11.42M | 10.47M | 9.50M | 9.53M | 9.61M |
| Operating Income | -3.12M | -3.02M | -2.91M | -2.36M | -1.82M |
| Income Before Tax | 508.10K | 14.11M | 27.66M | 27.18M | 26.68M |
| Income Tax Expenses | 9.50K | 5.20K | 800.00 | 102.30K | 206.20K |
| Earnings from Continuing Operations | 0.50 | 14.10 | 27.66 | 27.07 | 26.47 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 498.40K | 14.10M | 27.66M | 27.07M | 26.47M |
| EBIT | -3.12M | -3.02M | -2.91M | -2.36M | -1.82M |
| EBITDA | -3.08M | -2.98M | -2.87M | -2.34M | -1.81M |
| EPS Basic | 0.01 | 0.22 | 0.44 | 0.38 | 0.32 |
| Normalized Basic EPS | -0.04 | -0.03 | -0.03 | -0.20 | -0.37 |
| EPS Diluted | 0.01 | 0.22 | 0.44 | 0.38 | 0.32 |
| Normalized Diluted EPS | -0.04 | -0.03 | -0.03 | -0.20 | -0.37 |
| Average Basic Shares Outstanding | 301.58M | 285.07M | 268.57M | 208.04M | 147.51M |
| Average Diluted Shares Outstanding | 301.58M | 285.07M | 268.57M | 208.04M | 147.51M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |